Sysmex (OTCMKTS:SSMXY) Reaches New 1-Year Low at $16.95

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $16.95 and last traded at $17.32, with a volume of 21140 shares trading hands. The stock had previously closed at $26.08.

Sysmex Price Performance

The business's 50 day moving average is $17.95 and its 200-day moving average is $17.56. The firm has a market capitalization of $7.27 billion, a P/E ratio of 22.79 and a beta of 0.66. The company has a quick ratio of 2.27, a current ratio of 3.10 and a debt-to-equity ratio of 0.10.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its earnings results on Friday, February 9th. The company reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.16 by ($0.03). Sysmex had a net margin of 10.25% and a return on equity of 11.15%. The company had revenue of $770.84 million during the quarter. As a group, sell-side analysts predict that Sysmex Co. will post 0.86 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.